Eslam Maher
@eslammaher.bsky.social
📤 24
📥 119
📝 20
Oncology trials and biostatistics
https://scholar.google.co.uk/citations?user=ZbSK3WwAAAAJ
reposted by
Eslam Maher
London School of Hygiene & Tropical Medicine
about 15 hours ago
Paracetamol use during pregnancy does not increase risk of autism Laurie Tomlinson explains best available evidence shows
#paracetamol
safe to take during pregnancy & urges parents to seek reputable sources of information, & medical advice from GP.
www.lshtm.ac.uk/newsevents/n...
0
34
15
The Americas, Western Pacific, and Europe together hosted almost 90% of oncology trials worldwide. USA alone accounted for nearly 1/3rd...
www.nature.com/articles/s41...
loading . . .
The WHO global landscape of cancer clinical trials - Nature Medicine
This Review of the WHO’s International Clinical Trials Registry Platform presents a snapshot of the global cancer trial landscape and provides critical empirical evidence to inform policy, practice an...
https://www.nature.com/articles/s41591-025-03926-x
5 days ago
1
0
0
The C-index Multiverse
arxiv.org/abs/2508.14821
loading . . .
The C-index Multiverse
Quantifying out-of-sample discrimination performance for time-to-event outcomes is a fundamental step for model evaluation and selection in the context of predictive modelling. The concordance index, ...
https://arxiv.org/abs/2508.14821
5 days ago
0
0
0
CRAN's Task View for Clinical Trial Design, Monitoring, and Analysis has been updated in September 2025!
cran.r-project.org/web/views/Cl...
@thomasjaki.bsky.social
loading . . .
CRAN Task View: Clinical Trial Design, Monitoring, and Analysis
Get Started
https://cran.r-project.org/web/views/ClinicalTrials.html
5 days ago
0
0
0
UK clinical trials are under pressure
www.bmj.com/content/390/...
loading . . .
UK clinical trials are under pressure
Reducing administrative and regulatory hurdles could restore momentum The number of industry clinical trials conducted in the UK has fallen substantially in recent years, both in absolute terms and r...
https://www.bmj.com/content/390/bmj.r1883
6 days ago
0
0
0
FDA's draft guidance on the assessment of overall survival in oncology trials
www.fda.gov/regulatory-i...
loading . . .
Overall Survival in Oncology Clinical Trials
Approaches to Assessment of Overall Survival in Oncology Clinical Trials
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/approaches-assessment-overall-survival-oncology-clinical-trials
9 days ago
0
0
3
reposted by
Eslam Maher
Marion Campbell
16 days ago
I seem to have been discussing pilot and feasibility studies a lot this week. One question often asked is how big should my pilot/feasibility study be? 1/6
#MethodologyMonday
#124
1
17
9
reposted by
Eslam Maher
Suzie Cro
23 days ago
Are estimands being correctly used? A new review of protocols led by Timothy Clark shows many incorrectly defined estimand attributes. See the top areas for improvement & full results here:
trialsjournal.biomedcentral.com/articles/10....
#Trials
2
16
6
reposted by
Eslam Maher
NIHR Research Support Service (RSS)
27 days ago
We are excited to launch our new Research Methods Academy: Seminar Series! Hear from leading experts on innovative and best practice methods to strengthen your research proposal. Find out more and register:
www.nihr.ac.uk/news/nihr-la...
0
3
3
I think we need more studies like this, investigating OS surrogates in different malignancies:
www.sciencedirect.com/science/arti...
loading . . .
Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy
Surrogates for overall survival (OS) can expedite the development of adjuvant treatments for bladder cancer. We evaluated whether disease-free surviva…
https://www.sciencedirect.com/science/article/pii/S1078143925002698?via%3Dihub
30 days ago
0
0
0
Great resource 👇
add a skeleton here at some point
30 days ago
0
1
0
Prof
@vcornelius.bsky.social
@imperialctu.bsky.social
@statsci.bsky.social
inaugural lecture (in-person in Imperial & online)! 30 October 2025 "Under pressure: smarter trials for better health outcomes"
www.imperial.ac.uk/events/19688...
loading . . .
Under pressure: smarter trials for better health outcomes
Join us for Professor Victoria Cornelius' inaugural lecture in person or online.
https://www.imperial.ac.uk/events/196880/under-pressure/
about 1 month ago
0
2
0
reposted by
Eslam Maher
SCHARR Medical Statistics Group
about 1 month ago
onlinelibrary.wiley.com/doi/10.1002/...
loading . . .
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance
In adaptive clinical trials, the conventional confidence interval (CI) for a treatment effect is prone to undesirable properties such as undercoverage and potential inconsistency with the final hypot...
https://onlinelibrary.wiley.com/doi/10.1002/sim.70202
0
4
3
"You can't do good research without a good research acronym." — Doug Altman 😂
about 1 month ago
0
0
0
Word has it, statisticians are still looking for the perfect estimator.. "depletion of the susceptibles" and other HR limitations, a nice illustration:
link.springer.com/article/10.1...
loading . . .
How hazard ratios can mislead and why it matters in practice - European Journal of Epidemiology
Hazard ratios are routinely reported as effect measures in clinical trials and observational studies. However, many methodological works have raised concerns about the interpretation of hazard ratios ...
https://link.springer.com/article/10.1007/s10654-025-01250-9
about 1 month ago
0
0
0
ICH E20's draft on Adaptive Trials focuses almost exclusively on confirmatory trials. Early-phase designs make use of lots of adaptive elements, especially dose optimization, we need more than a paragraph..
www.ema.europa.eu/en/ich-e20-a...
loading . . .
ICH E20 adaptive designs for clinical trials - Scientific guideline | European Medicines Agency (EMA)
https://www.ema.europa.eu/en/ich-e20-adaptive-designs-clinical-trials-scientific-guideline
about 1 month ago
1
0
0
Is this the first ever drug approval for pediatrics with diffuse midline glioma? RANO ORR by BICR = 22% (95% CI: 12, 36), includes adults
www.fda.gov/drugs/resour...
loading . . .
FDA grants accelerated approval to dordaviprone
On August 6, 2025, the Food and Drug Administration granted accelerated approval to dordaviprone.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma
about 1 month ago
0
0
0
From
@timpmorris.bsky.social
et al's KMunicate guidance: "Interestingly, Paul Meier himself is said to have spoken with bemusement about people plotting KM estimates over time and was not convinced he actually liked it..."
bmjopen.bmj.com/content/9/9/...
loading . . .
Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate
Objectives To examine reactions to the proposed improvements to standard Kaplan–Meier plots, the standard way to present time-to-event data, and to understand which (if any) facilitated better depicti...
https://bmjopen.bmj.com/content/9/9/e030215
about 1 month ago
0
0
0
reposted by
Eslam Maher
Simon Gates
about 1 month ago
Job available for a statistician to work on a clinical trials methodology project on improving statistical methods for paediatric cancer ttrials. Cancer Research UK Clinical Trials Unit, University of Birmingham Closes 22 September
edzz.fa.em3.oraclecloud.com/hcmUI/Candid...
loading . . .
Biostatistician - Cancer Research UK Clinical Trials Unit - 105965 - Grade 7
This post is for a Biostatistician to be the main statistical scientist for a methodological project on improving statistical methods for the design and analysis of clinical trials in paediatric cance...
https://edzz.fa.em3.oraclecloud.com/hcmUI/CandidateExperience/en/sites/CX_6001/job/7685/?utm_medium=jobshare&utm_source=External+Job+Share
1
3
7
MRC HTMR Guidance pack
www.methodologyhubs.mrc.ac.uk/advice/netwo...
loading . . .
Network Hubs :: Guidance pack
https://www.methodologyhubs.mrc.ac.uk/advice/network-guidance/
about 1 month ago
0
0
0
FDA Oncology is organizing a virtual event on the future of registries Day 1: Best Practices for Innovation in Drug Development Day 2: Advancing Drug Development in Pediatric DMG/DIPG Register:
events.gcc.teams.microsoft.com/event/00d8a6...
loading . . .
Microsoft Virtual Events Powered by Teams
Microsoft Virtual Events Powered by Teams
https://events.gcc.teams.microsoft.com/event/00d8a6a6-971e-4af8-ae77-144bf2bc0db5@7d2fdb41-339c-4257-87f2-a665730b31fc
about 2 months ago
0
1
0
reposted by
Eslam Maher
Maarten van Smeden
3 months ago
Depending which methods guru you ask every analytical task is “essentially” a missing data problem, a causal inference problem, a Bayesian problem, a regression problem or a machine learning problem
5
59
9
reposted by
Eslam Maher
Frank Harrell
4 months ago
A senior machine learning expert at
@stanforduniversity.bsky.social
once interrupted a lecture of mine saying that
#MachineLearning
does not need a minimum sample size. I almost didn't know what to say. Almost.
1
10
4
you reached the end!!
feeds!
log in